CTLA4 is a negative regulator of T cell activation and its inhibition allows T cells’ response against cancer [20]; likewise, also the PD-1 axis is involved in the negative T cell regulation and its inhibition leads to the recovery of the cytotoxicity of T cells towards tumors [21]. This evidence concerns the gene CTLA4 and cancer.